Boothbay Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $8.42M | Buy |
|
|||||
2024
Q4 | – | Hold |
|
|||||
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $394K | Buy |
|
|||||
2023
Q2 | – | Hold |
|
|||||
2023
Q1 | – | Hold |
|
|||||
2022
Q2 | – | Hold |
|
|||||
2022
Q1 | – | Hold |
|
|||||
2021
Q4 | – | Sell |
|
|||||
2021
Q3 | $740K | Sell |
|
|||||
2021
Q2 | $1.59M | Hold |
|
|||||
2021
Q1 | $1.33M | Buy |
|
|||||
2020
Q4 | $1.16M | Sell |
|
|||||
2020
Q3 | $1.18M | Buy |
|
|||||
2020
Q2 | – | Sell |
|
|||||
2020
Q1 | $951K | Buy |
|
|||||
2019
Q4 | – | Hold |
|
|||||
2019
Q3 | – | Hold |
|
|||||
2019
Q2 | – | Hold |
|
|||||
2019
Q1 | – | Hold |
|
|||||
2018
Q4 | – | Sell |
|
|||||
2018
Q3 | $369K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $238K | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $186 | Buy |
|